”You’re a what?”
”Cervix.”
”You’re a what?”
”Cervical cancer…”
But then again, what exactly is cervical cancer? In short, in short, cervical cancer is a cancer O__O”…but not HPV infection will develop cervical cancer, its evolutionary history is like this: cervical lesions, early infiltrative cancer (also known as micro-infiltrative cancer of the cervix) – cervical cancer.
”You’re a what?”
”Cervical AI.”
”…”
1. Cervical lesions.
Narrowly defined as precancerous lesions of the cervix, including histologically confirmed squamous intraepithelial lesions and glandular intraepithelial lesions of the cervix.
Treatment strategies.
1) Destruction of the surface tissue of the cervix by physical therapy methods: cryotherapy, laser ablation, electrocautery and condensation, etc.
2) Removal of cervical tissue by excisional methods: cold knife conization, laser conization, electro-acupuncture conization, LEEP, etc.
Notes.
The treatment effect of the two methods is the same, but some treatment methods, such as cold knife conization and LEEP, can affect pregnancy and cause premature delivery, premature rupture of membranes and low birth weight babies
2.Early invasive cancer
Early stage cervical cancer which is difficult to be detected clinically and needs to be detected under microscope.
Treatment strategy
The traditional treatment for microinfiltrating cancer is surgical removal of the uterus. Nowadays, conservative treatment is preferred to preserve the patient’s reproductive function.
3.Cervical cancer
It is generally believed that women without persistent HPV infection have a very small chance of developing cervical cancer, while anal and genital infections with HPV are mostly related to age, sexual behavior and lifestyle habits. Although most young women are infected with HPV, it will mostly disappear automatically in women with normal immunity.
Cervical cancer screening.
1.The steps of cervical cancer screening are: cervical screening – colposcopic screening – histopathological screening.
2. the most commonly used screening methods include cervical cytology, high-risk HPV testing and visual observation method, which is mostly used in less developed areas and has a relatively low accuracy rate.
3.Population
Recommended screening methods.
Note
<21 years old
No need for cervical cancer screening
HPV testing for cervical screening, no triage test for ASC-US is prohibited
21-29 years old
Cervical cytology screening every 3 years
HPV should not be used for cervical screening
30~65 years old
Combined high-risk HPV and cervical cytology screening every 5 years
Cervical cytology screening alone every 3 years (acceptable)
In most cases, HPV testing is not recommended for cervical screening
>65 years of age
No further screening if prior cervical screening was sufficiently negative
Women with ≥CIN2 or history of cervical cancer treatment should continue routine screening for 20 years